A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient-Reference-Cited by-同舟云学术

A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient

Published:2016-05-05 Issue:6 Volume:21 Page:723-730
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Whitman Andrew M.¹,DeGregory Kathlene A.¹,Morris Amy L.¹,Ramsdale Erika E.²

Affiliation:

1. Department of Pharmacy Services, University of Virginia Health System, Charlottesville, Virginia, USA

2. Division of Hematology/Oncology, University of Virginia Health System, Charlottesville, Virginia, USA

Abstract

Abstract Inappropriate medication use and polypharmacy are extremely common among older adults. Numerous studies have discussed the importance of a comprehensive medication assessment in the general geriatric population. However, only a handful of studies have evaluated inappropriate medication use in the geriatric oncology patient. Almost a dozen medication screening tools exist for the older adult. Each available tool has the potential to improve aspects of the care of older cancer patients, but no single tool has been developed for this population. We extensively reviewed the literature (MEDLINE, PubMed) to evaluate and summarize the most relevant medication screening tools for older patients with cancer. Findings of this review support the use of several screening tools concurrently for the elderly patient with cancer. A deprescribing tool should be developed and included in a comprehensive geriatric oncology assessment. Finally, prospective studies are needed to evaluate such a tool to determine its feasibility and impact in older patients with cancer.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.2015-0492

Reference34 articles.

1. Association between potentially inappropriate medications from the Beers criteria and the risk of unplanned hospitalization in elderly patients;Price;Ann Pharmacother,2014

2. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: A prospective study of 1756 patients;Franceschi;Drug Saf,2008

3. Managing medications in clinically complex elders: “There’s got to be a happy medium.”;Steinman;JAMA,2010

4. Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutions;Page;Clin Interv Aging,2010

5. Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries;Mohile;J Natl Cancer Inst,2009

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of polypharmacy on the outcomes of older patients with advanced non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: A retrospective cohort study;Journal of Geriatric Oncology;2024-09

2. Polypharmacy and drug interactions in older patients with cancer receiving chemotherapy: associated factors;BMC Geriatrics;2024-06-25

3. Decreasing polypharmacy in older adults with cancer: A pilot cluster-randomized trial protocol;Journal of Geriatric Oncology;2024-03

4. Palliative radiotherapy in the older adult;Palliative Radiation Oncology;2024

5. Toxicity Derived from Interaction between Natural Compounds and Cancer Therapeutic Drugs Metabolized by CYP3A4: Lessons Learned from Two Clinical Case Reports;International Journal of Molecular Sciences;2023-11-05